Celanese Corp

Listed Company

CECIK 0001306830NYSELarge AcceleratedPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)DelawareFY ends Dec 31

Period

FY 2025

Revenue

$9.54B

Net Income

$-1.17B

Total Assets

$21.70B

Equity

$4.05B

Shares Out

109.66M

Op. Cash Flow

$1.15B

CE$45.70−21.91% · past yearDBEQ Basic

Daily closing prices

Business

Celanese Corporation is a global chemical and specialty materials company producing high-performance engineered polymers and acetyl products for automotive, medical, consumer electronics, construction, coatings, adhesives, and industrial applications. The company operates two main segments: Engineered Materials, which develops and commercializes advanced polymer solutions through a project-pipeline model; and the Acetyl Chain, an integrated value chain producing acetic acid, vinyl acetate monomer, emulsion polymers, and other intermediates. Celanese serves diverse multinational and regional customers through 51 global production facilities, strategic affiliates, and distribution partners across North America, Europe, and Asia.

Summary from 10-K filed 2026-02-24

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net sales	9,544	10,268	10,926	9,673	8,537
Cost of sales	−7,592	−7,932	−8,343	−7,293	−5,855
Gross profit	1,952	2,336	2,583	2,380	2,682
Selling, general and administrative expenses	−899	−1,033	−1,077	−824	−633
Amortization of intangible assets	−164	−159	−164	−62	−25
Research and development expenses	−125	−130	−146	−112	−86
Other (charges) gains, net	−1,581	−1,744	−68	−8	3
Foreign exchange gain (loss), net	36	24	32	−1	2
Gain (loss) on disposition of businesses and assets, net	−5	−14	505	5	3
Operating profit (loss)	−786	−720	1,665	1,378	1,946
Equity in net earnings (loss) of affiliates	127	196	102	220	146
Non-operating pension and other postretirement employee benefit (expense) income	55	−20	−69	17	106
Interest expense	−701	−676	−720	−405	−91
Refinancing expense	−68	0	−7	0	−9
Interest income	24	33	39	69	8
Dividend income - equity investments	122	128	126	133	147
Other income (expense), net	7	40	25	9	−5
Earnings (loss) from continuing operations before tax	−1,220	−1,019	1,161	1,421	2,248
Income tax (provision) benefit	90	−507	795	489	−330
Earnings (loss) from continuing operations	−1,130	−1,526	1,956	1,910	1,918
Earnings (loss) from operation of discontinued operations	−24	−10	−12	−9	−27
Income tax (provision) benefit from discontinued operations	3	2	3	1	5
Earnings (loss) from discontinued operations	−21	−8	−9	−8	−22
Net earnings (loss)	−1,151	−1,534	1,947	1,902	1,896
Net (earnings) loss attributable to noncontrolling interests	−14	−8	−4	−8	−6
Net earnings (loss) attributable to Celanese Corporation	−1,165	−1,542	1,943	1,894	1,890
Earnings (loss) from continuing operations	−1,144	−1,534	1,952	1,902	1,912
Earnings (loss) from discontinued operations	−21	−8	−9	−8	−22
Continuing operations - basic (in dollars per share)	−10.44	−14.04	17.93	17.55	17.19
Discontinued operations - basic (in dollars per share)	−0.2	−0.07	−0.08	−0.07	−0.2
Net earnings (loss) - basic (in dollars per share)	−10.64	−14.11	17.85	17.48	16.99
Continuing operations - diluted (in dollars per share)	−10.44	−14.04	17.84	17.41	17.06
Discontinued operations - diluted (in dollars per share)	−0.2	−0.07	−0.08	−0.07	−0.2
Net earnings (loss) - diluted (in dollars per share)	−10.64	−14.11	17.76	17.34	16.86
Weighted average shares - basic (in shares)	110	109	109	108	111
Weighted average shares - diluted (in shares)	110	109	109	109	112

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	1,263	962	1,805	1,508	536
Trade receivables - third party and affiliates, net	922	1,121	1,243	1,379	1,161
Non-trade receivables, net	545	493	541	675	506
Inventories	2,220	2,284	2,357	2,808	1,524
Assets held for sale	492	0	—	—	—
Other assets	251	266	272	241	80
Total current assets	5,693	5,126	6,218	6,611	3,807
Investments in affiliates	1,252	1,217	1,220	1,062	823
Property, plant and equipment, net	5,076	5,273	5,584	5,584	4,193
Operating lease right-of-use assets	359	388	422	413	236
Deferred income taxes	1,359	1,251	1,677	808	248
Other assets	601	555	524	547	521
Goodwill	4,171	5,387	6,977	7,142	1,412
Intangible assets, net	3,184	3,641	3,975	4,105	735
Total assets	21,695	22,838	26,597	26,272	11,975
Short-term borrowings and current installments of long-term debt - third party and affiliates	1,204	1,501	1,383	1,306	791
Trade payables - third party and affiliates	1,279	1,228	1,510	1,518	1,160
Liabilities held for sale	75	0	—	—	—
Other liabilities	1,049	1,157	1,154	1,201	473
Income taxes payable	76	4	25	43	81
Total current liabilities	3,683	3,890	4,072	4,068	2,505
Long-term debt, net of unamortized deferred financing costs	11,394	11,078	12,301	13,373	3,176
Deferred income taxes	512	923	999	1,242	555
Uncertain tax positions	208	286	300	322	280
Benefit obligations	344	396	457	411	558
Operating lease liabilities	265	294	325	364	200
Other liabilities	817	408	591	387	164
Commitments and Contingencies	—	—	—	—	—
Common stock, $0.0001 par value, 400,000,000 shares authorized (2025: 170,918,221 and 2024: 170,827,196 issued)	0	0	0	0	0
Treasury stock, at cost	−5,482	−5,486	−5,488	−5,491	−5,492
Additional paid-in capital	431	409	394	372	333
Retained earnings	9,876	11,054	12,929	11,274	9,677
Accumulated other comprehensive income (loss), net	−776	−848	−744	−518	−329
Total Celanese Corporation shareholders' equity	4,049	5,129	7,065	5,637	4,189
Noncontrolling interests	423	434	461	468	348
Total equity	4,472	5,563	7,526	6,105	4,537
Total liabilities and equity	21,695	22,838	26,597	26,272	11,975

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Asset impairment losses	1,513	1,639	15	14	2
Depreciation, amortization and accretion	786	823	739	478	378
Pension and postretirement net periodic benefit cost	8	6	13	−85	−136
Pension and postretirement contributions	−54	−54	−49	−48	−51
Actuarial (gain) loss on pension and postretirement plans	−45	37	66	81	41
Pension curtailments and settlements, net	−3	−9	1	0	3
Deferred income taxes, net	−278	213	−972	−835	13
(Gain) loss on disposition of businesses and assets, net	5	13	−501	−8	−5
Stock-based compensation	24	32	40	60	95
Undistributed earnings in unconsolidated affiliates	13	−33	55	−3	−34
Other, net	81	19	9	11	28
Operating cash provided by (used in) discontinued operations	12	−5	−2	−28	15
Trade receivables - third party and affiliates, net	213	92	105	218	−396
Inventories	154	11	398	−253	−367
Other assets	167	1	285	−13	−80
Trade payables - third party and affiliates	26	−234	20	−84	353
Other liabilities	−325	−51	−270	412	2
Net cash provided by (used in) operating activities	1,146	966	1,899	1,819	1,757
Capital expenditures on property, plant and equipment	−343	−435	−568	−543	−467
Acquisitions, net of cash acquired	0	0	52	−10,589	−1,142
Proceeds from sale of businesses and assets, net	21	0	480	48	—
Settlement of cross-currency swap agreement	0	17	0	0	—
Other, net	−27	−52	−98	−57	−53
Net cash provided by (used in) investing activities	−349	−470	−134	−11,141	−1,119
Net change in short-term borrowings with maturities of 3 months or less	8	15	−278	36	206
Proceeds from short-term borrowings	606	160	452	500	0
Repayments of short-term borrowings	−637	−418	−603	0	−6
Proceeds from long-term debt	4,352	328	3,001	10,769	990
Repayments of long-term debt	−4,652	−1,033	−3,660	−526	−786
Common stock dividends	−13	−307	−305	−297	−304
Distributions/dividends to noncontrolling interests	−30	−33	−11	−13	−27
Other, net	−147	−25	−52	−99	−43
Net cash provided by (used in) financing activities	−513	−1,313	−1,456	10,290	−1,042
Exchange rate effects on cash and cash equivalents	17	−26	−12	4	−15
Net increase (decrease) in cash and cash equivalents	301	−843	297	972	−419

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is Celanese Corp's CIK number?

Celanese Corp's SEC CIK number is 0001306830 (1306830). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find Celanese Corp's SEC filings?

All of Celanese Corp's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did Celanese Corp last report earnings?

Celanese Corp (CE) most recently filed an earnings 8-K with the SEC on May 5, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001306830-26-000091). This is Celanese Corp's most recent earnings filing of record — not a forecast of its next earnings date.

What is Celanese Corp's most recent earnings 8-K?

Celanese Corp's latest earnings 8-K (Item 2.02) was filed May 5, 2026 under accession 0001306830-26-000091. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View Celanese Corp's latest earnings 8-K →
Look up any company's CIK number →